Levodopa slows prosaccades and improves antisaccades: An eye movement study in Parkinson's disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 78, Issue 6, 2007, Pages 565-570

  Hood, Ashley J ^a   Amador, Silvia C ^a   Cain, Ashley E ^a   Briand, Kevin A ^a   Al Refai, Ali H ^b   Schiess, Mya C ^a   Sereno, Anne B ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIPARKINSON AGENT; CARBIDOPA; CARBIDOPA PLUS ENTACAPONE PLUS LEVODOPA; ENTACAPONE; LEVODOPA; PARAMIPEXOLE; PERGOLIDE; ROPINIROLE; UNCLASSIFIED DRUG;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CORNEA REFLEX; DRUG EFFECT; DRUG RESPONSE; FEMALE; FRONTAL LOBE; HUMAN; IDIOPATHIC DISEASE; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; RATING SCALE; RESPONSE TIME; SACCADIC EYE MOVEMENT; VOLUNTARY MOVEMENT; EYE MOVEMENT DISORDER; MIDDLE AGED; PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; REACTION TIME;

AGED; ANTIPARKINSON AGENTS; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; OCULAR MOTILITY DISORDERS; PARKINSON DISEASE; PSYCHOMOTOR PERFORMANCE; REACTION TIME; SACCADES;

EID: 34249741533     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2006.099754     Document Type: Article

References (28)

1. Jahanshahi M, Jenkins IH, Brown RG, et al. Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects. Brain 1995;118:913-33.
2. Playford ED, Jenkins IH, Passingham RE, et al. Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study. Ann Neurol 1992;32:151-61.
3. Cools R, Barker RA, Sahakian BJ, et al. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cereb Cortex 2001;11:1136-43.
4. Gotham AM, Brown RG, Marsden CD. 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off levodopa. Brain 1988;111:299-321.
5. Kulisevsky J. Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease. Drugs Aging 2000;16:365-79.
6. Lange KW, Robbins TW, Marsden CD, et al. L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction. Psychopharmacology (Berl) 1992;107:394-404.
7. Swainson R, Rogers RD, Sahakian BJ, et al. Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication. Neuropsychologic 2000;38:596-612.
8. Amador SC, Hood AJ, Schiess MC, et al. Dissociating cognitive deficits involved in voluntary eye movement dysfunctions in Parkinson's disease patients. Neuropsychologic 2006;44:1475-82.
9. Leigh RJ, Kennard C. Using saccades as a research tool in the clinical neurosciences. Brain 2004;127:460-77.
10. Pierrot-Deseilligny C, Milea D, Muri RM. Eye movement control by the cerebral cortex. Curr Opin Neurol 2004;17:17-25.
11. Astafiev SV, Shulman GL, Stanley CM, et al. Functional organization of human intraparietal and frontal cortex for attending, looking, and pointing. J Neurosci 2003;23:4689-99.
12. Briand KA, Hening W, Poizner H, et al. Automatic orienting of visuospatial attention in Parkinson's disease. Neuropsychologic 2001;39:1240-9.
13. Sereno AB, Holzman PS. Spatial selective attention in schizophrenic, affective disorder, and normal subjects. Schizophr Res 1996;20:33-50.
14. Sereno AB. Programming saccades: The role of attention. In: Raynard K, eds. Eye movements and visual cognition:scene perception and reading. New York: Springer Verlag, 1992:89-107.
15. Briand KA, Strallow D, Hening W, et al. Control of voluntary and reflexive saccades in Parkinson's disease. Exp Brain Res 1999;129:38-48.
16. Crevits L, De Ridder K. Disturbed striatoprefrontal mediated visual behaviour in moderate to severe parkinsonian patients. J Neurol Neurosurg Psychiatry 1997;63:296-9.
17. Fukushima J, Morita N, Fukushima K, et al. Voluntary control of saccadic eye movements in patients with schizophrenic and affective disorders. J Psychiatr Res 1990;24:9-24.
18. Minshew NJ, Luna B, Sweeney JA. Oculomotor evidence for neocortical systems but not cerebellar dysfunction in autism. Neurology 1999;52:917-22.
19. Munoz DP, Armstrong IT, Hampton KA, et al. Altered control of visual fixation and saccadic eye movements in attention-deficit hyperactivity disorder. J Neurophysiol 2003;90:503-14.
20. Sereno AB, Holzman PS. Antisaccades and smooth pursuit eye movements in schizophrenia. Biol Psychiatry 1995;37:394-401.
21. Larrison-Faucher AL, Matorin AA, Sereno AB. Nicotine reduces antisaccade errors in task impaired schizophrenic subjects. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:505-16.
22. Langston JW, Widner H, Goetz CG, et al. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 1992;7:2-13.
23. Schiess MC, Zheng H, Soukup VM, et al. Parkinson's disease subtypes: clinical classification and ventricular cerebrospinal fluid analysis. Parkinsonism Relat Disord 2000;6:69-76.
24. Vermersch AI, Rivaud S, Vidailhet M, et al. Sequences of memory-guided saccades in Parkinson's disease. Ann Neurol 1994;35:487-90.
25. Michell AW, Xu Z, Fritz D, et al. Saccadic latency distributions in Parkinson's disease and the effects of L-dopa. Exp Brain Res 2006;174:7-18.
26. Armstrong IT, Chan F, Riopelle RJ, et al. Control of saccades in Parkinson's disease. Brain Cogn 2002;49:198-201.
27. Deleu D, Northway MG, Hanssens Y. Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson's disease. Clin Pharmacokinet 2002;41:261-309.
28. Crevits L, Versijpt J, Hanse M, et al. Antisaccadic effects of a dopamine agonist as add-on therapy in advanced Parkinson's patients. Neuropsychobiology 2000;42:202-6.